Acne medication may delay progression of Multiple Sclerosis
A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and, if proven effective, will offer an inexpensive option for the treatment of early MS. Clinical researchers in Calgary and 13 other Canadian centres will be taking an in-depth look at an oral therapy known as minocycline after initial studies have shown promising results. A new $4 million multicentre clinical trial involving 200 participants from across Canada is being funded through the MS Society’s MS Scientific Research Foundation...
To read more, see link below to read MS Connections. (Edmonton and all of Alberta news on MS)
Attachment(s): MSConnectionsDec07.pdf